科济药业-B(02171.HK)授出674.05万份购股权及191.15万份受限制股份单位

Core Viewpoint - Company Kintor Pharmaceutical Co., Ltd. (02171.HK) announced the granting of stock options and restricted share units as part of its post-IPO incentive plans [1] Group 1: Stock Options - On September 18, 2025, the company granted a total of 6.7405 million stock options to 348 option grantees under the terms of its post-IPO stock option plan, pending acceptance by the grantees [1] Group 2: Restricted Share Units - On the same date, the company also granted 1.9115 million restricted share units to 196 grantees under the terms of its post-IPO restricted share unit plan, which is also subject to acceptance by the grantees [1]